Last week Pedro Silva, President of the Direction, and Bárbara Gomes, AccelBio’s CEO, were in Tel Aviv to get to know the Israeli innovation ecosystem.
With meetings with Tel Aviv University (Blavatnik Center for Drug Discovery) and Weizmann Institute of Science (Bina and Yeda), this was an excellent opportunity to learn about different perspectives and methodologies in the area of academic innovation and technology transfer.
We look forward to continuing our collaboration in the future.
Sign up with your email address to receive news and updates.
By subscribing to receive news and updates you are automatically agreeing with our Terms & Conditions and Privacy Policy.
CoLAB AccelBio had the privilege of hosting its first International Advisory Board (IAB) Meeting on February 26th, at Instituto de Medicina...
We are thrilled to announce the launch of the AccelBio Open Call, a competition aimed at accelerating biomedical innovation in Portugal. Our primary...
AccelBio participated in BioEurope event in Munich from November 6th to 8th, actively advancing the frontiers of biotech. With a commitment to...